Suppr超能文献

在结肠癌中,肿瘤芽生和肿瘤基质比率的评估中,异质性重要吗?

Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?

作者信息

Eriksen Ann C, Andersen Johnnie B, Lindebjerg Jan, dePont Christensen René, Hansen Torben F, Kjær-Frifeldt Sanne, Sørensen Flemming B

机构信息

Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark.

Department of Pathology, Danish Colorectal Cancer Center South, Vejle Hospital, Beriderbakken 4, DK-7100, Vejle, Denmark.

出版信息

Diagn Pathol. 2018 Mar 20;13(1):20. doi: 10.1186/s13000-018-0697-9.

Abstract

BACKGROUND

Tumour budding (TB) and Tumour Stroma Ratio (TSR) may be rewarding in the treatment stratification of patients with stage II colon cancer. However, lack of standardization may exclude these parameters from being used in a clinical setting. The purpose of this methodologic study was to compare stereology with semi-quantitative estimations of TSR, to investigate the intra-tumoural heterogeneity of TB and TSR, and to assess the intra- and inter-observer agreement.

METHODS

Three paraffin embedded tumour blocks, one of them representing the deepest invasive front, were selected from each of 43 patients treated for stage II colon cancer. TSR was estimated in H&E sections semi-quantitatively using conventional microscopy, and stereologically on scanned slides, using the newCAST stereology platform. TB was scored across 10 high power fields at the invasive front in cytokeratin AE1/AE3 stained sections.

RESULTS

Subjective, semi-quantitative estimates of TSR significantly correlated to the stereological estimates, with the best correlation found for sections with the deepest invasive tumour penetration (σ = 0.621, p < 0.001). Inter-observer agreement was moderate to substantial for both TB (Κappa = 0.46-0.73) and TSR (Κappa = 0.70-0.75). The Intraclass correlation coefficient (ICC) for TSR varied from 0.322 based on stereological hotspot estimation to 0.648 for the semi-quantitative evaluation. For TB, ICC varied from 0.646 based on continuous data to 0.698 based on categorical data (cut-off: 10 buds). Thus, the intra-tumoural heterogeneity for both TB and the semi-quantitative estimation of TSR was low.

CONCLUSION

We recommend using only one tissue section representing the deepest invasive tumour area for estimation of TSR. For TB we recommend using one tissue section; however due to low representation of high-budding tumours, results must be considered with caution.

摘要

背景

肿瘤芽生(TB)和肿瘤基质比(TSR)可能有助于II期结肠癌患者的治疗分层。然而,缺乏标准化可能会使这些参数无法应用于临床。本方法学研究的目的是比较体视学与TSR的半定量评估,研究TB和TSR的肿瘤内异质性,并评估观察者内和观察者间的一致性。

方法

从43例接受II期结肠癌治疗的患者中,各选取3个石蜡包埋的肿瘤块,其中1个代表最深浸润前沿。使用传统显微镜在苏木精-伊红(H&E)切片上对TSR进行半定量评估,并使用新型CAST体视学平台在扫描切片上进行体视学评估。在细胞角蛋白AE1/AE3染色切片的浸润前沿,在10个高倍视野中对TB进行评分。

结果

TSR的主观半定量评估与体视学评估显著相关,在肿瘤浸润最深的切片中相关性最佳(σ = 0.621,p < 0.001)。观察者间对TB(Kappa = 0.46 - 0.73)和TSR(Kappa = 0.70 - 0.75)的一致性为中等至高度。TSR的组内相关系数(ICC)从基于体视学热点估计的0.322到半定量评估的0.648不等。对于TB,ICC从基于连续数据的0.646到基于分类数据(截断值:10个芽)的0.698不等。因此,TB和TSR半定量评估的肿瘤内异质性均较低。

结论

我们建议仅使用一个代表肿瘤最深浸润区域的组织切片来评估TSR。对于TB,我们建议使用一个组织切片;然而,由于高芽生肿瘤的代表性较低,结果必须谨慎考虑。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a971/5859415/dce9feed6e92/13000_2018_697_Fig1_HTML.jpg

相似文献

1
2
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
Int J Colorectal Dis. 2018 Aug;33(8):1115-1124. doi: 10.1007/s00384-018-3076-9. Epub 2018 May 21.
4
Tumour Budding and Tumour Stroma Ratio are Reliable Predictors for Death and Recurrence in Elderly Stage I Colon Cancer Patients.
Pathol Res Pract. 2019 Nov;215(11):152635. doi: 10.1016/j.prp.2019.152635. Epub 2019 Sep 20.
5
Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study.
Int J Colorectal Dis. 2021 Dec;36(12):2729-2737. doi: 10.1007/s00384-021-04023-4. Epub 2021 Sep 17.
7
Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer.
Pathol Res Pract. 2018 Mar;214(3):402-407. doi: 10.1016/j.prp.2017.12.019. Epub 2018 Jan 2.
8
Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding.
Histopathology. 2020 May;76(6):906-918. doi: 10.1111/his.14070. Epub 2020 May 3.
9
The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact.
Histopathology. 2018 Aug;73(2):197-206. doi: 10.1111/his.13489. Epub 2018 Mar 24.
10
A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance.
Clin Transl Oncol. 2022 Jun;24(6):1047-1058. doi: 10.1007/s12094-021-02746-y. Epub 2022 Jan 22.

引用本文的文献

1
The Glasgow Microenvironment Score: an exemplar of contemporary biomarker evolution in colorectal cancer.
J Pathol Clin Res. 2024 Jul;10(4):e12385. doi: 10.1002/2056-4538.12385.
3
Tumor Stroma Ratio and Its Significance in Locally Advanced Colorectal Cancer.
Curr Oncol. 2022 May 3;29(5):3232-3241. doi: 10.3390/curroncol29050263.
5
Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study.
Int J Colorectal Dis. 2021 Dec;36(12):2729-2737. doi: 10.1007/s00384-021-04023-4. Epub 2021 Sep 17.
6
Prognostic Significance of Lacunarity in Preoperative Biopsy of Colorectal Cancer.
Pathol Oncol Res. 2020 Oct;26(4):2567-2576. doi: 10.1007/s12253-020-00851-x. Epub 2020 Jul 2.
7
Grainyhead-Like Genes Family May Act as Novel Biomarkers in Colon Cancer.
Onco Targets Ther. 2020 Apr 17;13:3237-3245. doi: 10.2147/OTT.S242763. eCollection 2020.
8
Tumor proportion in colon cancer: results from a semiautomatic image analysis approach.
Virchows Arch. 2020 Aug;477(2):185-193. doi: 10.1007/s00428-020-02764-1. Epub 2020 Feb 19.
9
The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
Int J Colorectal Dis. 2018 Aug;33(8):1115-1124. doi: 10.1007/s00384-018-3076-9. Epub 2018 May 21.

本文引用的文献

5
Tumour budding in colorectal cancer: what do we know and what can we do?
Virchows Arch. 2016 Apr;468(4):397-408. doi: 10.1007/s00428-015-1886-5. Epub 2015 Nov 27.
6
Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study.
Virchows Arch. 2015 May;466(5):485-93. doi: 10.1007/s00428-015-1740-9. Epub 2015 Feb 21.
8
Colorectal cancer.
Lancet. 2014 Apr 26;383(9927):1490-1502. doi: 10.1016/S0140-6736(13)61649-9. Epub 2013 Nov 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验